Blog

After a decade of rollout, the Drug Supply Chain Security Act (DSCSA) “track and trace” framework is now the operating reality for prescription drugs in the United States. If you make, repackage, wholesale, distribute, or dispense prescription drugs, you have legal duties to trace products electronically and to detect, quarantine, investigate, and report illegitimate products. … Read more

Compounding pharmacies fall into two very different legal categories in the United States: section 503A traditional pharmacies and section 503B outsourcing facilities. The difference is not just paperwork. It changes who you can supply, how you make drugs, what standards you must meet, and which regulators will show up at your door. If you operate … Read more

Compounded drugs fill real gaps in care. But the moment you promote them, you step into a thicket of FDA and FTC rules designed for safety and truthfulness. This article explains when you can legally advertise compounded drugs, what “off-label” promotion really means, and the missteps that can trigger warning letters, injunctions, or even multi‑million‑dollar … Read more

Two short words do most of the heavy lifting in FDA law: adulteration and misbranding. They sound technical. They are the power switch for enforcement. If your product is adulterated or misbranded, FDA can stop sales, seize stock, get an injunction, or refer a case for criminal charges. And yes, that includes something as small … Read more

Medicare Part D audits do not just verify that a drug was clinically appropriate. They examine whether the claim was valid, documented, and billed correctly. That’s why small clerical mistakes often lead to large clawbacks. Plans and their audit vendors assume that if a required element is missing or wrong, the claim was never payable. … Read more

Pharmacists often add “free” services to improve patient care—delivery, blister packs, prior authorization help, ride vouchers, loyalty points. The intent is good. The legal risk is real. Under federal fraud and abuse laws, “free” can be treated as a thing of value meant to influence choices. If those choices involve Medicare or Medicaid items or … Read more

A drug or device rep offers to cater lunch for your office and give a quick product talk. It feels harmless and common. In federal healthcare, it can be a crime. The Anti-Kickback Statute (AKS) makes it illegal to offer, pay, solicit, or receive anything of value to influence referrals or purchases reimbursed by Medicare, … Read more

You probably click through your annual Fraud, Waste, and Abuse (FWA) training between rushes. In pharmacy, that habit can cost you your job. FWA is not just a compliance acronym. It’s how payers, regulators, and auditors judge the daily decisions you make at the bench. Understanding what counts as fraud, what’s “only” abuse, and how … Read more

Most states now require clinicians to check their Prescription Drug Monitoring Program (PDMP) before writing certain controlled-substance prescriptions. The goal is to spot risky combinations, doctor shopping, and high doses before harm happens. The catch: the exact “when” varies by state, drug class, and clinical setting. Below is a practical guide to the common rules, … Read more

Pharmacists often assume the prescriber carries all the legal risk for a bad controlled-substance prescription. That is wrong. Under “corresponding responsibility,” you share legal duty for ensuring a controlled prescription is valid. If you knowingly, or with willful blindness, dispense a prescription that lacks a legitimate medical purpose or is outside the usual course of … Read more